AtriCure (ATRC) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.97 -0.56%
EPS Growth %: -300.0%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -300.0%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $52.9 million versus the consensus estimate of $51.56 million.
GUIDANCE:
AtriCure sees FY2019 revenue of $220-228 million, versus the consensus of $223.45 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AMTD Digital reports $1.2B in total assets, $42.4M profit
- Accenture shares fall on insider sales and analyst downgrade
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
